维普中文期刊产品整合服务
意见 帮助
基本检索 作者索引 机构索引 期刊索引
  • 哲学宗教
  • 社会学
  • 政治法律
  • 军事
  • 经济管理
  • 文化科学
  • 语言文字
  • 文学
  • 艺术
  • 历史地理
  • 自然科学总论
  • 理学
  • 天文地球
  • 生物学
  • 医药卫生
  • 农业科学
  • 一般工业技术
  • 矿业工程
  • 石油与天然气工程
  • 冶金工程
  • 金属学及工艺
  • 机械工程
  • 兵器科学与技术
  • 动力工程及工程热...
  • 核科学技术
  • 电气工程
  • 电子电信
  • 自动化与计算机技术
  • 化学工程
  • 轻工技术与工程
  • 建筑科学
  • 水利工程
  • 交通运输工程
  • 航空宇航科学技术
  • 环境科学与工程
时间 1989 - 2010 学科选择学科
题名/关键词 模糊
与 题名/关键词 模糊
重新搜索 在结果中搜索
17篇 您的检索式：作者名="Sugrue MM"
选中 清除  导出 查看参考文献 查看引证文献 引用追踪 共1页 首页 上一页 第1页 下一页 末页 /1 跳转
    题名 作者 年代 出处 被引量
1Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study(BRITE)显示文摘Grothey A Sugrue MM Purdie DM 0，，26：1
2Bevacizumab beyond first progression is associated with prolonged overall survival in metastaticcolorectal cancer: results from a large observational cohort study (BRiTE) 显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Onco2008，26，33：1
3Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)显示文摘Grothey A Sugrue MM Purdie DM 0，，33：1
4Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)显示文摘Grothey A Sugrue MM Purdie DM 0，，33：1
5p21(wafWcip1/sdi1) induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53显示文摘FANG L Igarashi M Leung J Sugrue MM Lee SW Aaronson SA 0，，：1
6Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE)显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
7Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53显示文摘Sugrue MM Shin DY Lee SW 1997Proc Natl Acad Sci U S A1997，94，18：1
8Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer : Resuhs from a large observational cohort study (BRiTE) 显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
9Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic eoloreetal cancer: results froro a large observational cohort study (BRiTE) 显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin 0ncol2008，26，33：1
10Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study(BRiTE)显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
11Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) 显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
12Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): results from the BRiTE observational cohort study显示文摘Kozloff MF Sugrue MM Purdie DM 2008J Clin Oncol2008，，：1
13Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer: results from a large observational cohort study (BRiTE) 显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
14Bevacizumab be- yond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRITE)显示文摘Grothey A Sugrue MM Purdie DM 2008Clin Oncol2008，26，33：1
15Bevacizumab beyond first progressaion is associated with prolonged overall survival in metastatic colorectal cancer:Results from a large observational cohort study(BRiTE)显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
16Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study (BRiTE)显示文摘Grothey A Sugrue MM Purdie DM 2008J Clin Oncol2008，26，33：1
17Bevacizumab beyond first progression is associated with prolonged overall survival in metastatic colorectal cancer:results from a large observational cohort study(BRiTE)显示文摘Grothey A Sugrue MM 2008J Clin Oncol2008，26，33：1
返回顶部 每页显示：
共1页 首页 上一页 第1页 下一页 末页 /1 跳转
goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费